Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products

被引:88
作者
Dunbar, JC [1 ]
Lu, HQ [1 ]
机构
[1] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA
关键词
leptin; agouti protein; beta-endorphin; alpha-melanocyte stimulating hormone; sympathetic nerve activity; blood pressure;
D O I
10.1016/S0361-9230(99)00197-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The mechanism underlying the leptin-induced increased sympathetic nerve activity and cardiovascular tone was investigated in normal rats. The melanocortin (MC) peptides and other fragments derived from proopiomelancortin (POMC) have a diverse array of biological activities and have been implicated in mediating the feeding behavioral responses to leptin. In this study we evaluated the possible involvement of two major products of POMC, alpha-melanocyte stimulating hormone (alpha-MSH) and beta-endorphin, in mediating the effects of leptin on sympathetic activity and mean arterial pressure (MAP) in normal rats. Intraventricular (i.c.v.) cannulas were implanted in normal rats and allowed to recover, On the day of the study the animals were anesthetized with urethane alpha-chloralose and instrumented for the recording of MAP, lumbar sympathetic nerve activity (LSNA), and heart rate (HR). To determine the correlation between the leptin response and the POMC products, alpha-MSH and beta-endorphins were also injected into the lateral ventricle. alpha-MSH acted to increase MAP and LSNA while p-endorphin decreased these parameters. Leptin administration by i.c.v. cannula increased the MAP and LSNA in normal rats. The i.c.v, administration of agouti protein, an alpha-MSH receptor antagonist, prior to leptin infusion blocked this response. Likewise, pretreatment with naloxone a beta-endorphin receptor antagonist also blocked the response to leptin. From these studies we conclude that the acute increased LSNA and MAP in response to i.c.v. leptin may be mediated by increased POMC and its subsequent production of breakdown product alpha-MSH and/or beta-endorphin and it is the subsequent action of alpha-MSH that increases MAP and LSNA by activation of the MC4 receptor. The naloxone antagonism of the leptin response is likely due to the blockade of presynaptic opioid inhibition of the MC4 receptor-mediated presser response. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 39 条
  • [21] CENTRAL ACTIONS OF CRF ON THERMOGENESIS ARE MEDIATED BY PROOPIOMELANOCORTIN PRODUCTS
    ROTHWELL, NJ
    HARDWICK, A
    LEFEUVRE, RA
    CROSBY, SR
    WHITE, A
    [J]. BRAIN RESEARCH, 1991, 541 (01) : 89 - 92
  • [22] Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system
    Satoh, N
    Ogawa, Y
    Katsuura, G
    Numata, Y
    Masuzaki, H
    Yoshimasa, Y
    Nakao, K
    [J]. NEUROSCIENCE LETTERS, 1998, 249 (2-3) : 107 - 110
  • [23] PRESSOR, TACHYCARDIC AND BEHAVIORAL EXCITATORY RESPONSES IN CONSCIOUS RATS FOLLOWING ICV ADMINISTRATION OF ACTH AND CRF ARE BLOCKED BY NALOXONE PRETREATMENT
    SAUNDERS, WS
    THORNHILL, JA
    [J]. PEPTIDES, 1986, 7 (04) : 597 - 601
  • [24] The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH
    Schioth, HB
    Muceniece, R
    Larsson, M
    Wikberg, JES
    [J]. JOURNAL OF ENDOCRINOLOGY, 1997, 155 (01) : 73 - 78
  • [25] Identification of targets of leptin action in rat hypothalamus
    Schwartz, MW
    Seeley, RJ
    Campfield, LA
    Burn, P
    Baskin, DG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) : 1101 - 1106
  • [26] Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus
    Schwartz, MW
    Seeley, RJ
    Woods, SC
    Weigle, DS
    Campfield, LA
    Burn, P
    Baskin, DG
    [J]. DIABETES, 1997, 46 (12) : 2119 - 2123
  • [27] Scoggins B A, 1984, J Hypertens Suppl, V2, pS67
  • [28] Chronic leptin infusion increases arterial pressure
    Shek, EW
    Brands, MW
    Hall, JE
    [J]. HYPERTENSION, 1998, 31 (01) : 409 - 414
  • [29] SITSEN JMA, 1982, J CARDIOVASC PHARM, V4, P883
  • [30] Effects of central injection of kyotorphin and L-arginine on oxytocin and vasopressin release and blood pressure in conscious rats
    Summy-Long, JY
    Bui, V
    Gestl, S
    Koehler-Stec, E
    Liu, HW
    Terrell, ML
    Kadekaro, M
    [J]. BRAIN RESEARCH BULLETIN, 1998, 45 (04) : 395 - 403